Literature DB >> 11932399

The conformation of the mature dimeric human immunodeficiency virus type 1 RNA genome requires packaging of pol protein.

M Shehu-Xhilaga1, M Hill, J A Marshall, J Kappes, S M Crowe, J Mak.   

Abstract

The packaging of a mature dimeric RNA genome is an essential step in human immunodeficiency virus type 1 (HIV-1) replication. We have previously shown that overexpression of a protease (PR)-inactive HIV-1 Gag-Pro-Pol precursor protein generates noninfectious virions that contain mainly monomeric RNA (M. Shehu-Xhilaga, S. M. Crowe, and J. Mak, J. Virol. 75:1834-1841, 2001). To further define the contribution of HIV-1 Gag and Gag-Pro-Pol to RNA maturation, we analyzed virion RNA dimers derived from Gag particles in the absence of Gag-Pro-Pol. Compared to wild-type (WT) dimeric RNAs, these RNA dimers have altered mobility and low stability under electrophoresis conditions, suggesting that the HIV-1 Gag precursor protein alone is not sufficient to stabilize the dimeric virion RNA structure. The inclusion of an active viral PR, without reverse transcriptase (RT) and integrase (IN), rescued the stability of the virion RNA dimers in the Gag particles but did not restore the mobility of the RNAs, suggesting that RT and IN are also required for virion RNA dimer maturation. Thin-section electron microscopy showed that viral particles deficient in RT and IN contain empty cone-shaped cores. The abnormal core structure indicates a requirement for Gag-Pro-Pol packaging during core maturation. Supplementing viral particles with either RT or IN via Vpr-RT or Vpr-IN alone did not correct the conformation of the dimer RNAs, whereas expression of both RT and IN in trans as a Vpr-RT-IN fusion restored RNA dimer conformation to that of the WT virus and also restored the electron-dense, cone-shaped virion core characteristic of WT virus. Our data suggest a role for RT-IN in RNA dimer conformation and the formation of the electron-dense viral core.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11932399      PMCID: PMC155102          DOI: 10.1128/jvi.76.9.4331-4340.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  In vitro assembly of human immunodeficiency virus type 1 Gag protein.

Authors:  Y Morikawa; T Goto; K Sano
Journal:  J Biol Chem       Date:  1999-09-24       Impact factor: 5.157

2.  Gag-Pol supplied in trans is efficiently packaged and supports viral function in human immunodeficiency virus type 1.

Authors:  M K Hill; C W Hooker; D Harrich; S M Crowe; J Mak
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA.

Authors:  R J Gorelick; S M Nigida; J W Bess; L O Arthur; L E Henderson; A Rein
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

4.  Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1.

Authors:  H G Göttlinger; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

5.  Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity.

Authors:  M Shehu-Xhilaga; S M Crowe; J Mak
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

6.  Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase.

Authors:  S Goff; P Traktman; D Baltimore
Journal:  J Virol       Date:  1981-04       Impact factor: 5.103

7.  Functional role of human immunodeficiency virus type 1 vpu.

Authors:  E F Terwilliger; E A Cohen; Y C Lu; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

8.  Proteolytic processing of the p2/nucleocapsid cleavage site is critical for human immunodeficiency virus type 1 RNA dimer maturation.

Authors:  M Shehu-Xhilaga; H G Kraeusslich; S Pettit; R Swanstrom; J Y Lee; J A Marshall; S M Crowe; J Mak
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

9.  Overexpression of the gag-pol precursor from human immunodeficiency virus type 1 proviral genomes results in efficient proteolytic processing in the absence of virion production.

Authors:  J Park; C D Morrow
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

10.  Electron microscopy of human immunodeficiency virus.

Authors:  D J Hockley; R D Wood; J P Jacobs; A J Garrett
Journal:  J Gen Virol       Date:  1988-10       Impact factor: 3.891

View more
  22 in total

1.  Molecular factors required for human immunodeficiency virus type I infectivity.

Authors:  A G Bukrinskaya; G K Vorkunova; M E Burshteĭn; T V Gorodnicheva; M Stevenson
Journal:  Dokl Biol Sci       Date:  2005 Jul-Aug

2.  Allosteric HIV-1 Integrase Inhibitors Lead to Premature Degradation of the Viral RNA Genome and Integrase in Target Cells.

Authors:  Michaela K Madison; Dana Q Lawson; Jennifer Elliott; Ayşe Naz Ozantürk; Pratibha C Koneru; Dana Townsend; Manel Errando; Mamuka Kvaratskhelia; Sebla B Kutluay
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

3.  Analysis of human immunodeficiency virus type 1 reverse transcriptase subunit structure/function in the context of infectious virions and human target cells.

Authors:  Alok Mulky; John C Kappes
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

4.  Replication of chimeric human immunodeficiency virus type 1 (HIV-1) containing HIV-2 integrase (IN): naturally selected mutations in IN augment DNA synthesis.

Authors:  Marcus Padow; Lilin Lai; Champion Deivanayagam; Lawrence J DeLucas; Robert B Weiss; Diane M Dunn; Xiaoyun Wu; John C Kappes
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

5.  Accurately measuring recombination between closely related HIV-1 genomes.

Authors:  Timothy E Schlub; Redmond P Smyth; Andrew J Grimm; Johnson Mak; Miles P Davenport
Journal:  PLoS Comput Biol       Date:  2010-04-29       Impact factor: 4.475

6.  Subunit-specific analysis of the human immunodeficiency virus type 1 reverse transcriptase in vivo.

Authors:  Alok Mulky; Stefan G Sarafianos; Edward Arnold; Xiaoyun Wu; John C Kappes
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

7.  The dimer initiation sequence stem-loop of human immunodeficiency virus type 1 is dispensable for viral replication in peripheral blood mononuclear cells.

Authors:  M K Hill; M Shehu-Xhilaga; S M Campbell; P Poumbourios; S M Crowe; J Mak
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

8.  Relationships between infectious titer, capsid protein levels, and reverse transcriptase activities of diverse human immunodeficiency virus type 1 isolates.

Authors:  Andre J Marozsan; Erika Fraundorf; Awet Abraha; Heather Baird; Dawn Moore; Ryan Troyer; Immaculate Nankja; Eric J Arts
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

9.  In vitro dimerization of human immunodeficiency virus type 1 (HIV-1) spliced RNAs.

Authors:  Lucile Sinck; Delphine Richer; Jane Howard; Marina Alexander; Damian F J Purcell; Roland Marquet; Jean-Christophe Paillart
Journal:  RNA       Date:  2007-10-09       Impact factor: 4.942

10.  The A-rich RNA sequences of HIV-1 pol are important for the synthesis of viral cDNA.

Authors:  Cameron P Keating; Melissa K Hill; David J Hawkes; Redmond P Smyth; Catherine Isel; Shu-Yun Le; Ann C Palmenberg; John A Marshall; Roland Marquet; Gary J Nabel; Johnson Mak
Journal:  Nucleic Acids Res       Date:  2008-12-23       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.